CReATe: Investigating Biomarkers for Primary Progressive Multiple Sclerosis and Hereditary Spastic Paraplegia
22 feb 2023 ·
2 min. 27 sec.
Iscriviti gratuitamente
Ascolta questo episodio e molti altri. Goditi i migliori podcast su Spreaker!
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
New research from the Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium. This summary is based on a paper published in the International Journal of Molecular...
mostra di più
New research from the Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium. This summary is based on a paper published in the International Journal of Molecular Sciences on November 3, 2022, titled "Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers in Primary Progressive Multiple Sclerosis and Hereditary Spastic Paraplegia Type 4."
Read the paper here: https://www.mdpi.com/1422-0067/23/21/13466
Learn more about CReATe: https://www1.rarediseasesnetwork.org/cms/create/
mostra meno
Read the paper here: https://www.mdpi.com/1422-0067/23/21/13466
Learn more about CReATe: https://www1.rarediseasesnetwork.org/cms/create/
Informazioni
| Autore | RDCRN |
| Organizzazione | RDCRN |
| Sito | - |
| Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
